Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanyan Fang

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
The AAPS Journal|May 2, 2022
Application of Modeling and Simulation to Identify a Shortened Study Duration and Novel Bioequivalence Metric for a Long-Acting Intrauterine SystemSatish Sharan, Sungwoo Choi, Yuan Zou, et al.
Pain Medicine (Malden, Mass.)|December 5, 2021
Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of AbuseSrikanth C Nallani, Wenjing Li, Silvia N Calderon, et al.
The AAPS Journal|February 27, 2024
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDALanyan Fang, Yuqing Gong, Andrew C Hooker, et al.
Pharmaceutical Research|May 28, 2025
Using Model Master Files to Support Oral Drug Product Development and Regulatory SubmissionsYi-Hsien Cheng, Arindom Pal, Rebecca Moody, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 4, 2023
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary reportAbdullah Al Shoyaib, Arian Emami Riedmaier, Anita Kumar, et al.
Journal of Medicinal Chemistry|February 3, 2006
Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistanceLanyan Fang, Guisheng Zhang, Chenglong Li, et al.
Pharmaceutical Research|March 27, 2025
PBPK Modeling to Support Bioavailability and Bioequivalence Assessment in Pediatric PopulationsFang Wu, Eleftheria Tsakalozou, Gilbert J Burckart, et al.
Statistical Methods in Medical Research|July 14, 2025
Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designsFlorence Loingeville, Manel Rakez, Thu Thuy Nguyen, et al.
The AAPS Journal|June 29, 2023
Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case StudyGopal Pawar, Fang Wu, Liang Zhao, et al.
Journal of Medicinal Chemistry|October 13, 2006
Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugatesLanyan Fang, Robert F Battisti, Hao Cheng, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
The AAPS Journal|May 2, 2022
Application of Modeling and Simulation to Identify a Shortened Study Duration and Novel Bioequivalence Metric for a Long-Acting Intrauterine SystemSatish Sharan, Sungwoo Choi, Yuan Zou, et al.
Pain Medicine (Malden, Mass.)|December 5, 2021
Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of AbuseSrikanth C Nallani, Wenjing Li, Silvia N Calderon, et al.
The AAPS Journal|February 27, 2024
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDALanyan Fang, Yuqing Gong, Andrew C Hooker, et al.
Pharmaceutical Research|May 28, 2025
Using Model Master Files to Support Oral Drug Product Development and Regulatory SubmissionsYi-Hsien Cheng, Arindom Pal, Rebecca Moody, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 4, 2023
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary reportAbdullah Al Shoyaib, Arian Emami Riedmaier, Anita Kumar, et al.
Journal of Medicinal Chemistry|February 3, 2006
Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistanceLanyan Fang, Guisheng Zhang, Chenglong Li, et al.
Pharmaceutical Research|March 27, 2025
PBPK Modeling to Support Bioavailability and Bioequivalence Assessment in Pediatric PopulationsFang Wu, Eleftheria Tsakalozou, Gilbert J Burckart, et al.
Statistical Methods in Medical Research|July 14, 2025
Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designsFlorence Loingeville, Manel Rakez, Thu Thuy Nguyen, et al.
The AAPS Journal|June 29, 2023
Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case StudyGopal Pawar, Fang Wu, Liang Zhao, et al.
Journal of Medicinal Chemistry|October 13, 2006
Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugatesLanyan Fang, Robert F Battisti, Hao Cheng, et al.
Pageof 7